FASN and prostate carcinoma: According to a previous report [12], pentagalloyl glucose suppressed rat liver microsomal 5α-reductase activity and expression of the androgen receptor in prostate cells, resulting in a significant reduction in androgen-induced prostate cancer cell growth and fatty acid synthase by pentagalloyl glucose.